UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SPCX
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.94% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
6126
NeoVolta
NEOV
$205M
| $547K | ﹤0.01% |
173,800
-65,128
| -27% | -$165K |
|
|
MNTN
6127
MNTN Inc
MNTN
$848M
| $547K | ﹤0.01% |
59,471
-112,156
| -65% | -$1.02M |
|
6128
PRA Group
PRAA
$774M
| $547K | ﹤0.01% |
28,785
-461,322
| -94% | -$8.2M |
|
6129
Global X Genomics & Biotechnology ETF
GNOM
$97.3M
| $546K | ﹤0.01% |
9,603
-1,023
| -10% | -$48.8K |
|
6130
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$894M
| $544K | ﹤0.01% |
12,453
+9,926
| +393% | +$476K |
|
6131
Codexis
CDXS
$145M
| $542K | ﹤0.01% |
239,907
-1,943,868
| -89% | -$4.84M |
|
|
DSM
6132
BNY Mellon Strategic Municipal Bond Fund
DSM
$271M
| $542K | ﹤0.01% |
88,101
-4,417
| -5% | -$26.9K |
|
|
PCG.PRX
6133
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.1B
| $542K | ﹤0.01% |
13,093
+569
| +5% | +$23.8K |
|
6134
Invesco International Corporate Bond ETF
PICB
$350M
| $539K | ﹤0.01% |
23,294
+4,243
| +22% | +$99.4K |
|
6135
Arrow Financial
AROW
$706M
| $539K | ﹤0.01% |
13,149
-30,960
| -70% | -$1.15M |
|
|
FTH
6136
Faeth Therapeutics
FTH
$908M
| $539K | ﹤0.01% |
21,541
+17,012
| +376% | +$393K |
|
6137
Medifast
MED
$134M
| $533K | ﹤0.01% |
50,223
+36,390
| +263% | +$420K |
|
6138
CALL
Zoetis
ZTS
$30.2B
| $533K | ﹤0.01% |
7,412
+5,634
| +317% | +$530K |
|
6139
CALL
Wave Life Sciences
WVE
$875M
| $531K | ﹤0.01% |
+91,400
| New | +$606K |
|
|
WIW
6140
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
$500M
| $530K | ﹤0.01% |
63,150
-2,270
| -3% | -$19.3K |
|
|
MMID
6141
MFS Active Mid Cap ETF
MMID
$34.3M
| $528K | ﹤0.01% |
+20,000
| New | +$511K |
|
6142
Delcath Systems
DCTH
$564M
| $525K | ﹤0.01% |
41,714
-27,425
| -40% | -$303K |
|
6143
MMTec
MTC
$653M
| $524K | ﹤0.01% |
209,791
+137,923
| +192% | +$733K |
|
6144
Fidelity Enhanced Large Cap Growth ETF
FELG
$5.68B
| $524K | ﹤0.01% |
11,981
+6,032
| +101% | +$257K |
|
6145
iShares US Tech Independence Focused ETF
IETC
$697M
| $523K | ﹤0.01% |
4,873
-828
| -15% | -$86.3K |
|
6146
Syntec Optics
OPTX
$271M
| $522K | ﹤0.01% |
41,965
-4,461
| -10% | -$44.5K |
|
6147
Magnachip Semiconductor
MX
$103M
| $522K | ﹤0.01% |
110,336
-73,110
| -40% | -$354K |
|
|
ILOW
6148
AB International Low Volatility Equity ETF
ILOW
$1.85B
| $522K | ﹤0.01% |
11,479
+9,700
| +545% | +$434K |
|
|
GTEN
6149
Gores Holdings X
GTEN
| $522K | ﹤0.01% |
50,000
| – | – |
|
|
ADAG
6150
Adagene
ADAG
$226M
| $521K | ﹤0.01% |
124,063
+120,061
| +3,000% | +$452K |
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.